Cryoport, Inc. (CYRX) vs The Toro Company (TTC)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| CYRX | TTC | |
|---|---|---|
| Sector | Industrials | Industrials |
| Industry | Integrated Freight & Logistics | Tools & Accessories |
| Size band | SMALL | MID |
| Listing | Nasdaq CM | NYSE |
| Country | United States | United States |
| Theme | cell-therapy | industrial-machinery |
| Price and returns | ||
| Last close | $17.79 | $105.46 |
| Return · 1 week | +4.77% | +5.03% |
| Return · 1 month | +2.36% | +8.64% |
| Return · 3 months | +17.27% | +10.63% |
| Return · year to date | +86.09% | +32.10% |
| Return · 1 year | +71.06% | +42.82% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −5.02% | −1.32% |
| 52-week high | $18.73 | $106.87 |
| 52-week low | $7.61 | $67.64 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $901.05M | $9.97B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $10.14M | $71.49M |
| Employees | 684 | 9,227 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 24.79× |
| Price to earnings · forward | n/a (negative forward earnings) | 18.24× |
| Price to sales | 4.88× | 1.85× |
| Price to book | 2.05× | 6.46× |
| Enterprise value to EBITDA | n/a (negative EBITDA) | 14.37× |
| Enterprise value to revenue | 4.25× | 2.04× |
| PEG ratio | n/a (negative earnings) | 1.46 |
| Earnings per share · trailing | -0.81 | 3.74 |
| Profitability | ||
| Gross margin | 47.08% | 33.41% |
| Operating margin | −20.45% | 13.98% |
| Profit margin | −21.94% | 7.64% |
| Return on equity | −6.54% | 26.45% |
| Return on assets | −2.39% | 9.36% |
| Growth | ||
| Revenue growth | +7.70% | +8.40% |
| Earnings growth | — | +49.80% |
| Balance sheet and payout | ||
| Debt / equity (%) | 47.28 | 80.67 |
| Current ratio | 2.08 | 1.58 |
| Dividend yield | 0.00% | 1.68% |
| Payout ratio | 0.00% | 41.44% |
| Trend and volatility | ||
| RSI · 14 | 56.15 | 63.74 |
| ADX · 14 | 17.21 | 14.03 |
| 50-day average | $16.77 | $96.87 |
| 200-day average | $13.15 | $94.47 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 4.06% | 2.02% |
The full CYRX analysis
Everything this table leaves out for Cryoport, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the CYRX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full CYRX analysisThe full TTC analysis
Everything this table leaves out for The Toro Company: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the TTC argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full TTC analysis